✦ LIBER ✦

Phase II Trial of Debulking Surgery and Photodynamic Therapy for Disseminated Intraperitoneal Tumors

✍ Scribed by Samantha K. Hendren; Stephen M. Hahn; Francis R. Spitz; Todd W. Bauer; Stephen C. Rubin; Timothy Zhu; Eli Glatstein; Douglas L. Fraker

Publisher: Springer
Year: 2001
Tongue: English
Weight: 65 KB
Volume: 8
Category: Article
ISSN: 1068-9265
DOI: 10.1007/s10434-001-0065-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study of debulking surgery and p

Phase I study of debulking surgery and photodynamic therapy (PDT) for peritoneal carcinomatosis

✍ T.F. DeLaney; W.F. Sindelar; Z. Tochner; L. Dachowski; P. Smith; W. Friauf; G. T 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Phase III randomized trial of surgery wi

Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma

✍ Harvey I. Pass; Barbara K. Temeck; Karen Kranda; Gunther Thomas; Angelo Russo; P 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 592 KB

A Phase II trial of gemcitabine for meta

A Phase II trial of gemcitabine for metastatic neuroendocrine tumors

✍ Matthew H. Kulke; Haesook Kim; Jeffrey W. Clark; Peter C. Enzinger; Thomas J. Ly 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

## Abstract ## BACKGROUND Treatment with traditional cytotoxic chemotherapy regimens containing streptozocin or dacarbazine has resulted in only marginal benefit for patients with metastatic neuroendocrine tumors. The use of these regimens has been further limited by their potential toxicity. Gemc

Phase II trial of vinblastine sulfate fo

Phase II trial of vinblastine sulfate for metastatic urothelial tract tumors

✍ Martin S. Blumenreich; Alan Yagoda; Ronald B. Natale; Robin C. Watson 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 578 KB

Vinblastine sulfate, 0.10-0.15 mg/kg IV every week, was given to 37 patients with bidimensionally measurable, metastatic transitional cell carcinoma of the urothelial tract. Twenty-eight patients, the majority of whom had received extensive prior chemotherapy, had an adequate trial and five (18%; 95

Cooperative clinical trial of photodynam

Cooperative clinical trial of photodynamic therapy with photofrin II and excimer dye laser for early gastric cancer

✍ Mimura, Seishiro; Ito, Yoshiaki; Nagayo, Takeo; Ichii, Makoto; Kato, Harubumi; S 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 415 KB

Background and Objectiue: Photodynamic therapy (PDT) is a recently developed endoscopic method for treating malignant tumors. For obtaining more photodynamic action with less thermal effect, we employed as the excitation light source for PDT an excimer dye laser, which is a pulsed laser with extreme

Phase I/II trial for the treatment of cu

Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy

✍ Richard Heller; Mark J. Jaroszeski; L. Frank Glass; Jane L. Messina; David P. Ra 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 868 KB

## BACKGROUND. Electroporation is a process that causes a transient increase in the permeability of cell membranes. It can be used to increase the intracellular concentration of chemotherapeutic agents in tumor cells (electrochemotherapy; ECT). A clinical study was initiated to determine if this m